Archive for October, 2008

Nu Skin Science Unlocks a Secret

 

PROVO, Utah · Oct. 23, 2008 /PRNewswire/ — Current anti-aging products merely address the superficial signs of aging, like wrinkling and skin texture, but today Nu Skin Enterprises, Inc. (NYSE:NUS) introduces its breakthrough anti-aging ageLOC™ technology that when incorporated into Nu Skin’s skin care lineup not only slows a newly discovered age-causing enzyme at its source, but also demonstrates visible benefits in the form of smoother, brighter, more youthful-looking skin. “Consumers in every economic category are spending money on anti-aging products, whether it’s for a $30 jar of cream or invasive treatments costing thousands of dollars, but no solution has yet to do what ageLOC technology offers,” said Ashok Pahwa, chief marketing officer at Nu Skin Enterprises. “We believe ageLOC technology will propel Nu Skin to the forefront of the anti-aging industry by attacking aging where it is happening, before you even see it. Our science is unlocking a secret to how you age.” This first-to-market anti-aging technology from Nu Skin is the result of more than six years of research and development. ageLOC employs a patent-pending ingredient blend to help diminish the negative visible effects caused by a newly discovered internal source of aging and offers a scientific explanation to why some people may look younger or older than their actual age. Revolutionary ageLOC technology will first be available in the reformulated Nu Skin Galvanic Spa Facial Gels. The Nu Skin Galvanic Spa System II is currently the company’s best-selling product line in several markets and has already demonstrated the ability to offer visible results of cleaner, firmer and more radiant skin in as little as five minutes twice a week. The addition of ageLOC technology to this core product lineup is a natural fit. “We believe that by slowing an inherent source of aging in the epidermis, the skin benefits are visibly obvious,” said Helen Knaggs, Ph.D., vice president of Nu Skin global research and development. “A recent consumer use study demonstrates the visible benefits of this strategy.”

ageLOC Consumer Use Study

While ageLOC technology is designed to help prevent the visible effects of aging at their source, a recent consumer use study also identifies a significant corrective benefit. Study participants who used the Galvanic Spa Facial Gels with ageLOC reported greater improvements in skin attributes than those using the original Galvanic gels. Participants in the ageLOC group graded their skin texture 30 percent better than did the participants using the original gels. Similarly, they believed their results for skin health were 20 percent better, improvement in skin clarity was 13 percent more and improvement in skin brightness was 11 percent more.

About the Galvanic Spa System

Galvanic Spa Facial Gels with ageLOC are used in combination with the Galvanic Spa device. The Nu Skin Galvanic Spa System II includes a patented, handheld device that uses self-adjusting, low-level galvanic currents to help transport key ingredients to the skin for a revived and rejuvenated appearance. Galvanic treatments operate on the basic principle that like charges repel and opposites attract. When paired with proprietary Nu Skin products formulated with either a negative or positive charge, and when programmed with the same polarity, the Nu Skin Galvanic Spa instrument repels treatment products, assisting with the delivery of active ingredients to the skin. The Galvanic Pre-Treat Gel has a negative charge, and the Treatment Gel with ageLOC technology has a positive charge.

About ageLOC Technology

ageLOC technology is the result of collaborative research from scientists at Nu Skin and Purdue University, and is designed to inhibit a newly identified age-related enzyme found on external cell membranes, including in the epidermis. Age-related NADH oxidase, or arNOX, is an internal free radical generator that increases in activity as you age. In a clinical study conducted with Stanford University, clinical graders concluded that study participants with higher levels of arNOX appeared an average of seven years older, while participants with lower levels of arNOX appeared an average of seven years younger. For more details: http://www.prnewswire.com/mnr/nuskin/35618/

Post to Twitter

Technorati Tags: , ,

  • Share/Bookmark

, ,

Comments

The Appearance Of Aging And Arnox

 

 

 

Scientists from Nu Skin Enterprises Inc. presented the results of a breakthrough study at the 25th International Federation of Societies of Cosmetic Chemists Congress (IFSCC) in Barcelona revealing a correlation between levels of a newly identified age-related enzyme, arNOX, and a person’s appearance. The study, conducted at Stanford University, demonstrated that women with higher activity levels of arNOX appeared an average of seven years older than their chronological age, while women with decreased activity levels of the enzyme appeared to be seven years younger than their actual age, on average. “Demonstrating arNOX as a source of certain visible signs of aging validates our strategic focus of attacking the sources of aging,” said Joe Chang, Ph.D., chief scientific officer at Nu Skin. “Merely repairing damage to the skin from environmental and mechanical stresses is no longer sufficient for savvy consumers.” “The ground-breaking conclusions in this research, combined with trends of an aging demographic, lead us to believe that there is sizable market potential for a product that inhibits arNOX activity, and thus slows the appearance of certain signs of aging,” said Ashok Pahwa, chief marketing officer at Nu Skin. “Additionally, the lines between personal care and nutrition are blurring,” continued Pahwa. “Savvy consumers are increasingly aware of the link between nutrition and beauty, and industry analysts report that products to postpone aging will perhaps witness the strongest demand in upcoming years.” Nu Skin currently holds patents and exclusive patent rights to arNOX inhibitors and plans to commercialize the scientific advances under its new product platform branded as ageLOC. The first topical ageLOC application will be launched later this month. Because the arNOX enzyme is present throughout the body, not just in the epidermis, the company is also conducting additional studies to better understand the broader applications of ageLOC technology in nutritional supplementation.

Post to Twitter

Technorati Tags: , , , ,

  • Share/Bookmark

, , , ,

Comments

New Ageloc Ad Campaign Starts

Post to Twitter

Technorati Tags: ,

  • Share/Bookmark

,

Comments